Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The organellar redox environment, specifically within the lysosomal and endoplasmic reticulum (ER) membranes, refers to the localized balance of reactive oxygen species (ROS) and antioxidant systems essential for cellular homeostasis [3]. The ER requires a relatively oxidizing environment to facilitate proper protein folding and disulfide bond formation, while lysosomes utilize redox-sensitive mechanisms for degradation and nutrient sensing [4]. Disrupting this environment is an emerging therapeutic strategy in oncology, where agents are designed to induce localized oxidative stress [2]. Certain transition metal complexes, such as those based on ruthenium, osmium, or iridium, are engineered to accumulate in these specific membranes [1]. Upon activation, these compounds generate ROS that cause lysosomal membrane permeabilization and ER stress [1]. This dual-targeting approach often leads to immunogenic cell death (ICD), which stimulates the host's immune system against tumor cells [5]. Unlike traditional targets like single enzymes or receptors, the organellar redox environment represents a physiological state that can be modulated to bypass conventional drug resistance [2]. However, achieving precise targeting without systemic toxicity remains a significant challenge in the development of these agents [2].
Induction of localized oxidative stress through the generation of reactive oxygen species (ROS), leading to lysosomal membrane permeabilization (LMP), endoplasmic reticulum (ER) stress, and the subsequent induction of immunogenic cell death (ICD).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organellar redox environment (Lysosomal and Endoplasmic Reticulum membranes).